vs
Side-by-side financial comparison of Eastern Bankshares, Inc. (EBC) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
Eastern Bankshares, Inc. is the larger business by last-quarter revenue ($295.9M vs $207.8M, roughly 1.4× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 22.1%, a 35.3% gap on every dollar of revenue.
Eastern Bank is a bank based in Boston, Massachusetts. Before de-mutualizing in 2020, it was the oldest and largest mutual bank in the United States and the largest community bank in Massachusetts.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
EBC vs IDYA — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $295.9M | $207.8M |
| Net Profit | $65.3M | $119.2M |
| Gross Margin | — | — |
| Operating Margin | — | 52.2% |
| Net Margin | 22.1% | 57.4% |
| Revenue YoY | 710.6% | — |
| Net Profit YoY | -34.4% | 330.1% |
| EPS (diluted) | $0.29 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $295.9M | — | ||
| Q4 25 | $37.5M | — | ||
| Q3 25 | $241.5M | $207.8M | ||
| Q2 25 | $244.9M | — | ||
| Q1 25 | $31.1M | — | ||
| Q4 24 | $216.5M | — | ||
| Q3 24 | $203.4M | $0 | ||
| Q2 24 | $154.0M | $0 |
| Q1 26 | $65.3M | — | ||
| Q4 25 | $99.5M | — | ||
| Q3 25 | $106.1M | $119.2M | ||
| Q2 25 | $100.2M | — | ||
| Q1 25 | $-217.7M | — | ||
| Q4 24 | $60.8M | — | ||
| Q3 24 | $-6.2M | $-51.8M | ||
| Q2 24 | $26.3M | $-52.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 38.9% | 52.2% | ||
| Q2 25 | 41.0% | — | ||
| Q1 25 | -590.9% | — | ||
| Q4 24 | 33.3% | — | ||
| Q3 24 | -1.6% | — | ||
| Q2 24 | 24.7% | — |
| Q1 26 | 22.1% | — | ||
| Q4 25 | 265.6% | — | ||
| Q3 25 | 44.0% | 57.4% | ||
| Q2 25 | 40.9% | — | ||
| Q1 25 | -699.2% | — | ||
| Q4 24 | 28.1% | — | ||
| Q3 24 | -3.0% | — | ||
| Q2 24 | 17.1% | — |
| Q1 26 | $0.29 | — | ||
| Q4 25 | $0.48 | — | ||
| Q3 25 | $0.53 | $1.33 | ||
| Q2 25 | $0.50 | — | ||
| Q1 25 | $-1.08 | — | ||
| Q4 24 | $0.29 | — | ||
| Q3 24 | $-0.03 | $-0.60 | ||
| Q2 24 | $0.16 | $-0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $551.7M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.3B | $1.1B |
| Total Assets | $30.6B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $551.7M | — | ||
| Q4 25 | $507.6M | — | ||
| Q3 25 | $703.4M | $786.9M | ||
| Q2 25 | $948.3M | — | ||
| Q1 25 | $609.0M | — | ||
| Q4 24 | $1.9B | — | ||
| Q3 24 | $1.7B | $920.0M | ||
| Q2 24 | $1.4B | $701.7M |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | — | ||
| Q3 25 | $3.8B | $1.1B | ||
| Q2 25 | $3.7B | — | ||
| Q1 25 | $3.6B | — | ||
| Q4 24 | $3.6B | — | ||
| Q3 24 | $3.7B | $1.2B | ||
| Q2 24 | $3.0B | $931.7M |
| Q1 26 | $30.6B | — | ||
| Q4 25 | $30.6B | — | ||
| Q3 25 | $25.5B | $1.2B | ||
| Q2 25 | $25.5B | — | ||
| Q1 25 | $25.0B | — | ||
| Q4 24 | $25.6B | — | ||
| Q3 24 | $25.5B | $1.2B | ||
| Q2 24 | $21.0B | $973.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $142.2M |
| Free Cash FlowOCF − Capex | — | $142.2M |
| FCF MarginFCF / Revenue | — | 68.4% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $432.4M | — | ||
| Q3 25 | $157.1M | $142.2M | ||
| Q2 25 | $123.9M | — | ||
| Q1 25 | $47.3M | — | ||
| Q4 24 | $283.8M | — | ||
| Q3 24 | $108.3M | $-49.2M | ||
| Q2 24 | $54.3M | $-32.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | — | $-33.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 68.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 4.35× | — | ||
| Q3 25 | 1.48× | 1.19× | ||
| Q2 25 | 1.24× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.67× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.06× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
